Westfield Capital Management’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2016
Q3 | – | Sell |
-2,946,519
| Closed | -$148M | – | 274 |
|
2016
Q2 | $148M | Buy |
2,946,519
+285,978
| +11% | +$14.4M | 1.22% | 15 |
|
2016
Q1 | $142M | Sell |
2,660,541
-1,280,909
| -32% | -$68.5M | 1.08% | 24 |
|
2015
Q4 | $259M | Sell |
3,941,450
-1,613,980
| -29% | -$106M | 1.74% | 4 |
|
2015
Q3 | $314M | Sell |
5,555,430
-302,161
| -5% | -$17.1M | 2.22% | 3 |
|
2015
Q2 | $346M | Buy |
5,857,591
+266,720
| +5% | +$15.8M | 2.11% | 3 |
|
2015
Q1 | $348M | Buy |
5,590,871
+932,152
| +20% | +$58.1M | 2.01% | 5 |
|
2014
Q4 | $268M | Sell |
4,658,719
-28,806
| -0.6% | -$1.66M | 1.58% | 7 |
|
2014
Q3 | $252M | Sell |
4,687,525
-481,029
| -9% | -$25.9M | 1.54% | 6 |
|
2014
Q2 | $271M | Buy |
5,168,554
+256,191
| +5% | +$13.4M | 1.61% | 6 |
|
2014
Q1 | $260M | Sell |
4,912,363
-261,676
| -5% | -$13.8M | 1.55% | 5 |
|
2013
Q4 | $207M | Buy |
+5,174,039
| New | +$207M | 1.22% | 8 |
|